Access to FFPE tissue should be as diverse as the disease itself.
Discovery Life Sciences takes a Science at Your Service™ approach to provide scientists worldwide with a diverse range of highly characterized (hyper-annotated™) human FFPE biospecimens to accelerate precision oncology programs.
Quality
Capture reliable data with Discovery’s rigorous FFPE sample integrity
Access
Streamline selection with unmatched access and actionable data
Insight
Build smarter FFPE cohorts with integrated target expression screening services
Smarter Cohorts.
Reliable FFPE Selection with Digital H&E Slides
- Nearly 30,000 blocks with digital H&E images so you can order with confidence
Actionable Sample Data
- Including tumor percentage, tumor enriched area, 4-micron sections, etc.
- Molecular pathology results included where available
Sample Integrity
- All pathology data are confirmed by Discovery’s board-certified pathologists
Faster Timelines.
Quick Sample Delivery
- Rapid sample delivery after purchase, usually within 10 business days
Sortable Inventory Report
- Quickly identify blocks that match your criteria by sorting and filtering the comprehensive inventory report
Unmatched Access
- With over 30,000 quality reviewed blocks in inventory, Discovery can provide the samples you need to accelerate your research
FFPE Technical Resources
Need biomarker characterization for your FFPE tissue?
While our biospecimens are highly characterized, we also provide streamlined multi-omic biomarker analyses to further characterize biospecimens from our inventory or from your studies via our global CLIA / CAP service laboratories.*
- HudsonAlpha Discovery
- Whole Genome Sequencing
- Whole Exome Sequencing
- Targeted Panels
- Long-read sequencing
- RNASeq
- Single Cell Sequencing
- Multiplexed & Singleplex IHC
- In-Situ Hybridization
- RNAScope
- Digital Pathology & Image analysis
- PCR
- Immunofluorescence
- Colorimetric
*HudsonAlpha Discovery Sequencing & Bioinformatics laboratory is CLIA registered, pending CAP accreditation.
